| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 39.18B | 38.48B | 36.38B | 35.55B | 33.87B | 31.32B |
| Gross Profit | 9.19B | 8.88B | 8.49B | 8.47B | 8.18B | 7.41B |
| EBITDA | 5.00B | 4.78B | 4.58B | 4.44B | 4.32B | 3.62B |
| Net Income | 3.38B | 3.21B | 3.05B | 2.92B | 2.79B | 2.28B |
Balance Sheet | ||||||
| Total Assets | 49.98B | 52.02B | 50.81B | 48.17B | 46.82B | 44.31B |
| Cash, Cash Equivalents and Short-Term Investments | 23.71B | 24.30B | 27.13B | 24.04B | 24.20B | 21.53B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 6.72B | 8.54B | 8.95B | 8.39B | 8.70B | 8.12B |
| Stockholders Equity | 43.26B | 43.47B | 41.86B | 39.78B | 38.12B | 36.19B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.40B | 4.59B | 2.91B | 2.77B | 2.13B |
| Operating Cash Flow | 0.00 | 1.57B | 4.71B | 2.95B | 2.93B | 2.24B |
| Investing Cash Flow | 0.00 | -3.09B | -1.14B | -1.34B | -57.84M | 342.11M |
| Financing Cash Flow | 0.00 | -1.61B | -983.76M | -1.26B | -703.42M | -983.52M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥54.93B | 21.15 | ― | 1.71% | 12.01% | 16.50% | |
76 Outperform | €51.38B | 15.22 | 8.36% | 3.01% | 6.48% | 8.22% | |
74 Outperform | ¥55.82B | 15.75 | ― | 1.69% | 15.59% | 22.71% | |
73 Outperform | €70.71B | 18.12 | 32.57% | 2.31% | 9.79% | 42.15% | |
70 Outperform | ¥49.39B | 12.82 | ― | 3.09% | 4.32% | -6.09% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
61 Neutral | ¥63.09B | 82.95 | ― | 0.63% | 18.44% | ― |